Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

SLNO holding history

Soleno Therapeutics Inc in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLNO overviewAll 13F holders of SLNOFull Q4 2025 holdings

Shares (Q4 2025)
3,060,361
Value
$141.7M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of SLNO by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20253,060,361$141.7M<0.1%+253,212+9.0%AddedHolders
Q3 20252,807,149$189.8M<0.1%+319,317+12.8%AddedHolders
Q2 20252,487,832$208.4M<0.1%+621,506+33.3%AddedHolders
Q1 20251,866,326$133.3M<0.1%−18,207−1.0%ReducedHolders
Q4 20241,884,533$84.7M<0.1%+303,806+19.2%AddedHolders
Q3 20241,580,727$79.8M<0.1%+77,974+5.2%AddedHolders
Q2 20241,502,753$61.3M<0.1%+533,098+55.0%AddedHolders
Q1 2024969,655$41.5M<0.1%+330.0%AddedHolders
Q4 2023969,622$39.0M<0.1%+914,371+1,654.9%AddedHolders
Q3 202355,251$1.63M<0.1%+5,312+10.6%AddedHolders
Q2 202349,939$214.2K<0.1%00.0%UnchangedHolders
Q1 202349,939$106.9K<0.1%00.0%UnchangedHolders
Q4 202249,939$98.9K<0.1%−71,147−58.8%ReducedHolders
Q3 2022121,086$202.0K<0.1%−14,634−10.8%ReducedConverted for a 1-for-15 splitHolders
Q2 20222,035,806$377.0K<0.1%−16,045−0.8%ReducedHolders
Q1 20222,051,851$457.0K<0.1%−12,541−0.6%ReducedHolders
Q4 20212,064,392$846.0K<0.1%−4,120−0.2%ReducedHolders
Q3 20212,068,512$1.91M<0.1%00.0%UnchangedHolders
Q2 20212,068,512$2.36M<0.1%−272,910−11.7%ReducedHolders
Q1 20212,341,422$2.95M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.